An international team of researchers has achieved a breakthrough in the production of doxorubicin, a vital chemotherapy agent. The study identifies and resolves molecular "bottlenecks" that have ...

Merck & Co., Inc. (NYSE:MRK) has been on a strong recovery run, gaining 23% over the past year and 8% year-to-date, though the stock has pulled back some, now well below its 52-week high of $125.14.

A gene called FOXJ1 may drive resistance to taxane chemotherapy during treatment for advanced prostate cancer, according to a new study led by investigators at Weill Cornell Medicine and Beth Israel ...

Advances in cancer treatment mean that more people than ever are surviving the disease. However, some of the most effective ...

Advances in cancer treatment mean that more people than ever are surviving the disease. However, some of the most effective ...

Advances in cancer treatment mean that more people than ever are surviving the disease. However, some of the most effective ...

A study, published in Basic Research in Cardiology, demonstrates in an experimental model that the heart can be protected during anthracycline treatment using a simple, non-pharmacological technique ...

- First trial participant treated with PTM-101, an investigational thin film formulation of paclitaxel placed directly over the tumor for continuous localized drug exposure - - Trial enrolling ...

Describes the nature of a clinical study. Types include: Observational study — observes people and measures outcomes without affecting results. Interventional study (clinical trial) — studies new ...